GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nutex Health Inc (NAS:NUTX) » Definitions » 14-Day RSI

Nutex Health (Nutex Health) 14-Day RSI

: 26.08 (As of Today)
View and export this data going back to 2022. Start your Free Trial

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-04-23), Nutex Health's 14-Day RSI is 26.08.

The industry rank for Nutex Health's 14-Day RSI or its related term are showing as below:

NUTX's 14-Day RSI is ranked better than
94.65% of 691 companies
in the Healthcare Providers & Services industry
Industry Median: 44.32 vs NUTX: 26.08

Competitive Comparison

For the Health Information Services subindustry, Nutex Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutex Health 14-Day RSI Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Nutex Health's 14-Day RSI falls into.



Nutex Health  (NAS:NUTX) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nutex Health  (NAS:NUTX) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Nutex Health 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Nutex Health's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutex Health (Nutex Health) Business Description

Traded in Other Exchanges
N/A
Address
6030 S. Rice Ave, Suite C, Houston, TX, USA, 77081
Nutex Health Inc is healthcare services and operations company with 19 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Executives
Thomas T. Vo director, officer: Chairman, CEO 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Joshua Detillio officer: Chief Operating Officer 6030 S. RICE AVENUE, SUITE C, HOUSTON TX 77081
Jon Christian Bates officer: Chief Financial Officer 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Mitchell Creem director 700 NORTH BRAND BLVD., SUITE 450, GLENDALE CA 91203
Pamela W. Montgomery officer: Chief Legal Off. & Secretary 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Michael Lee Reed director 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Cheryl Yvonne Grenas director 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
John J Waters director 2165 TECHNOLOGY DRIVE, SCHENECTADY NY 12308
Danniel Stites director 3050 S. DOBSON ROAD, CHANDLER AZ 85248
Premier Macy Management Holdings, Llc 10 percent owner 2819 CYPRESS DRIVE, TEXARKANA TX 75503
Michael Bowen officer: Chief Financial Officer 501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701
Warren Hosseinion director C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Lawrence Schimmel officer: Chief Medical Information Off 5193 SW 75TH STREET, MIAMI FL 33143
Frederick Sternberg officer: President of subsidiary 10772 SANDY RUN RD, JUPTIER FL 33478
Micro Hospital Holding Llc 10 percent owner 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081